---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-070212"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-06-18T21:15:27+00:00"
generated_at: "2026-06-18T21:16:46.986257+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma regains compliance with Nasdaq minimum bid price rule

## Summary
- Received Nasdaq confirmation on June 17, 2026, that it regained compliance with Listing Rule 5550(a)(2).
- Closing bid price was $1.00 or greater from June 3 to June 16, 2026, satisfying the requirement.
- Nasdaq considers the matter closed; SILO continues trading on the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-070212
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-06-18T21:15:27+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/0001213900-26-070212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/ea0295339-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-070212
- JSON: https://secwatch.observer/filing/0001213900-26-070212.json
- Plain text: https://secwatch.observer/filing/0001213900-26-070212.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.